Robert C. Tait

13.2k total citations · 1 hit paper
168 papers, 8.7k citations indexed

About

Robert C. Tait is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert C. Tait has authored 168 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 44 papers in Molecular Biology and 43 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert C. Tait's work include Blood Coagulation and Thrombosis Mechanisms (48 papers), Venous Thromboembolism Diagnosis and Management (35 papers) and Hemophilia Treatment and Research (30 papers). Robert C. Tait is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (48 papers), Venous Thromboembolism Diagnosis and Management (35 papers) and Hemophilia Treatment and Research (30 papers). Robert C. Tait collaborates with scholars based in United Kingdom, United States and Netherlands. Robert C. Tait's co-authors include Isobel D. Walker, David Keeling, Trevor Baglin, Raymond L. Rodriguez, Herbert W. Boyer, Henry G. Watson, Michael Makris, David J. Perry, J A Conkie and S I A M Islam and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert C. Tait

161 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines on oral anticoagulation with warfarin – fourth edition

2011 396 citations Trevor Baglin, Robert C. Tait et al. British Journal of Haematology profile →

Peers

Countries citing papers authored by Robert C. Tait

Since Specialization

Citations

This map shows the geographic impact of Robert C. Tait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Tait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Tait more than expected).

Fields of papers citing papers by Robert C. Tait

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Tait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Tait. The network helps show where Robert C. Tait may publish in the future.

Co-authorship network of co-authors of Robert C. Tait

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Tait. A scholar is included among the top collaborators of Robert C. Tait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Tait. Robert C. Tait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B 2023 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Frank W.G. Leebeek, Karin Fijnvandraat, Michiel Coppens, Mary Mathias, Peter W. Collins, Robert C. Tait, Catherine Bagot, Nicola Curry, Jeanette Payne, Pratima Chowdary, Marjon H. Cnossen, Ron A. A. Mathôt	3
2	New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia 2021 ·Thrombosis and Haemostasis ·Jan Astermark, Cihan Ay, Manuela Carvalho, Roseline d’Oiron, Philippe de Moerloose, Gerard Dolan, Pierre Fontana, Cédric Hermans, Pål André Holme, Όλγα Κατσαρού, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, (unknown), Ramiro Núñez, Ingrid Pabinger, Robert C. Tait, Paul van der Valk	0
3	Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study 2021 ·Blood Advances ·Paul van der Valk, Michael Makris, Kathelijn Fischer, Robert C. Tait, Pratima Chowdary, Peter W. Collins, Karina Meijer, Lize F. D. van Vulpen, Eveline P. Mauser‐Bunschoten, Roger E. G. Schutgens	18
4	A new pedigree with thrombomodulin‐associated coagulopathy in which delayed fibrinolysis is partially attenuated by co‐inherited TAFI deficiency 2020 ·Journal of Thrombosis and Haemostasis ·Sarah K. Westbury, Claire S. Whyte, Jonathan Stephens, Kate Downes, Ernest Turro, (unknown), (unknown), Dirk Hendriks, Anne‐Louise Latif, Emma Leishman, Nicola J. Mutch, Robert C. Tait, Andrew Mumford	21
5	British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE) 2018 ·Thorax ·Luke Howard, (unknown), Robin Condliffe, V. Connolly, Christopher W.H. Davies, (unknown), (unknown), C.M. Free, Daniel Horner, Laura Hunter, (unknown), Catherine Nelson‐Piercy, Emma O’Dowd, Raj Patel, (unknown), Karen Sheares, Robert C. Tait	55
6	Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data 2015 ·Journal of Thrombosis and Haemostasis ·Maura Marcucci, Alfonso Iorio, James D. Douketis, Sabine Eichinger, Alberto Tosetto, Trevor Baglin, Mary Cushman, Gualtiero Palareti, Daniela Poli, Robert C. Tait, Paul A. Kyrle	43
7	Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts 2015 ·Journal of Thrombosis and Haemostasis ·R.E.J. Roach, Willem M. Lijfering, Robert C. Tait, Trevor Baglin, Paul A. Kyrle, Suzanne C. Cannegieter, Frits R. Rosendaal	21
8	Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences 2013 ·Journal of Clinical Epidemiology ·Maura Marcucci, Catrin Tudur Smith, James D. Douketis, Alberto Tosetto, Trevor Baglin, Mary Cushman, Sabine Eichinger, Gualtiero Palareti, Daniela Poli, Robert C. Tait, Alfonso Iorio	6
9	Increased prevalence of hypertension in haemophilia patients 2012 ·Thrombosis and Haemostasis ·(unknown), Kathelijn Fischer, Michael Makris, Robert C. Tait, Peter W. Collins, Karina Meijer, G. Roosendaal, Pratima Chowdary, Roger E. G. Schutgens, Eveline P. Mauser‐Bunschoten	58
10	Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis 2010 ·Journal of Thrombosis and Haemostasis ·Trevor Baglin, James D. Douketis, Alberto Tosetto, Maura Marcucci, Mary Cushman, Paul A. Kyrle, Gualtiero Palareti, Daniela Poli, Robert C. Tait, Alfonso Iorio	149
11	Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations 2008 ·Thrombosis and Haemostasis ·Robert C. Tait, Don W. Shaffer, F. Baudo, B Boneu, (unknown), Marie Hélène Horellou, Robert Klamroth, John Lazarchick, Andrew Mumford, Sam Schulman, Caroline Shiach, (unknown), Johan Frieling, Jacqueline Conard, (unknown), Andreas Tiede	27
12	Dementia in subjects with atrial fibrillation; haemostatic function and the role of anticoagulation (vol 33, pg 10, 2004) 2005 ·ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) ·Mark Barber, (unknown), Ann Rumley, John R. Scott, DJ Stott, Robert C. Tait	4
13	Adenomyoepithelioma of the breast 2005 ·Robert C. Tait, Sarah E. Pinder, Ian O. Ellis, Arnie Purushotham	1
14	Are Atrial Fibrillation Guidelines Altering Management? A Community Based Study 2005 ·Scottish Medical Journal ·(unknown), Kathleen O’Neill, Jeanne Jackson, Alex D. McMahon, Ann Rumley, (unknown), G.D.O. Lowe, Robert C. Tait	7
15	A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state 2001 ·British Journal of Haematology ·(unknown), Isobel D. Walker, Alex D. McMahon, S I A M Islam, Robert C. Tait	174
16	The cancer-associated retinopathy antigen is a recoverin-like protein. 1992 ·PubMed ·Charles E. Thirkill, Robert C. Tait, Nancy K. Tyler, Alan M. Roth, John L. Keltner	159
17	Antithrombin Cambridge II, 384 Ala to Ser Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins 1991 ·FEBS Letters ·David J. Perry, Mary E. Daly, Paul Harper, Robert C. Tait, John C. Price, Isobel D. Walker, Robin W. Carrell	44
18	Human brain glycogen phosphorylase: characterization of fetal cDNA and genomic sequences 1989 ·Molecular Brain Research ·(unknown), (unknown), (unknown), Robert C. Tait, Fredric A. Gorin	23
19	Plant phosphoglucose isomerase genes lack introns and are expressed in Escherichia coli 1988 ·Plant Molecular Biology ·Robert C. Tait, (unknown), Debbie Laudencia‐Chingcuanco, L. D. Gottlieb	12
20	Recombinant DNA techniques : an introduction 1983 ·Andalas University Repository (Andalas University) ·Raymond L. Rodriguez, Robert C. Tait	258

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact